A claim was made on the one hand for a patent infringement, and on the other it was challenged. The patent related to recombinant erythropoietin.
Held: The claim 19 was invalid (for insufficiency) but that claim 26 was valid and infringed.
Judges:
The Hon Mr Justice Neuberger
Citations:
[2002] EWHC 471 (Patents)
Links:
Jurisdiction:
England and Wales
Cited by:
Appeal from – Kirin Amgen Inc and others v Hoechst Marion Roussel Ltd and others CA 31-Jul-2002
The claimants sought damages for infringement of their patent. The defendants denied infringement, and sought a revocation of the patent.
Held: The patent concerned gene technology. Although an error had been made, the patent was valid, since . .
At First Instance – Kirin-Amgen Inc and others v Hoechst Marion Roussel Limited and others etc HL 21-Oct-2004
The claims arose in connection with the validity and alleged infringement of a European Patent on erythropoietin (‘EPO’).
Held: ‘Construction is objective in the sense that it is concerned with what a reasonable person to whom the utterance . .
Lists of cited by and citing cases may be incomplete.
Intellectual Property
Updated: 28 July 2022; Ref: scu.170015
